This $140M contract to Chartwell RX LLC for essential antibiotics signals robust government demand for pharmaceutical preparedness, directly benefiting generic drug manufacturers like Teva Pharmaceutical Industries Ltd. ($TEVA) and Viatris Inc. ($MYL) through increased market stability and potential supply chain opportunities.
Impact: 6/10Federal Contract